Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 25, 2015 - Issue 4
Submit an article Journal homepage
4,696
Views
64
CrossRef citations to date
0
Altmetric
Review

Therapeutic uses of furin and its inhibitors: a patent review

Frédéric CoutureUniversité de Sherbrooke, Institut de Pharmacologie de Sherbrooke, Department of Surgery/Urology Division, Faculté de Médecine et des Sciences de la Santé, 3001 12e Ave. Nord, Sherbrooke, Québec, J1H 5N4, Canada+1 819 564 5428; +1 819 564 5400; [email protected]
,
Anna KwiatkowskaUniversité de Sherbrooke, Institut de Pharmacologie de Sherbrooke, Department of Surgery/Urology Division, Faculté de Médecine et des Sciences de la Santé, 3001 12e Ave. Nord, Sherbrooke, Québec, J1H 5N4, Canada+1 819 564 5428; +1 819 564 5400; [email protected]
,
Yves L DoryUniversité de Sherbrooke, Institut de Pharmacologie de Sherbrooke, Département de chimie, Faculté des Sciences, Sherbrooke, Québec, Canada
&
Robert DayUniversité de Sherbrooke, Institut de Pharmacologie de Sherbrooke, Department of Surgery/Urology Division, Faculté de Médecine et des Sciences de la Santé, 3001 12e Ave. Nord, Sherbrooke, Québec, J1H 5N4, Canada+1 819 564 5428; +1 819 564 5400; [email protected]
Pages 379-396 | Published online: 07 Jan 2015

Citations (64)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dhiman Chandra Paul, Minakshi Bhattacharjee, Dhani Ram Mahato & Manash Pratim Sarma. (2023) Natural furin inhibitor(s) as potent therapeutic molecule to mitigate SARS-CoV-2 infection. Journal of Biomolecular Structure and Dynamics 41:15, pages 7365-7371.
Read now

Articles from other publishers (63)

Karin Löw, Rebecca Möller, Cora Stegmann, Miriam Becker, Laura Rehburg, Helena Obernolte, Dirk Schaudien, Lisa Oestereich, Armin Braun, Stefan Kunz & Gisa Gerold. (2023) Luminescent reporter cells enable the identification of broad‐spectrum antivirals against emerging viruses. Journal of Medical Virology 95:11.
Crossref
Shanping Ji & Steven H. L. Verhelst. (2023) Furin-targeting activity-based probes with phosphonate and phosphinate esters as warheads. Organic & Biomolecular Chemistry 21:32, pages 6498-6502.
Crossref
Lisa E.J. Douglas, James A. Reihill, Bethany M. Montgomery & S. Lorraine Martin. (2023) Furin as a therapeutic target in cystic fibrosis airways disease. European Respiratory Review 32:168, pages 220256.
Crossref
Wei Yang, Junjun Cao, David G. McVey & Shu Ye. (2023) Allele-Specific Epigenetic Regulation of FURIN Expression at a Coronary Artery Disease Susceptibility Locus. Cells 12:13, pages 1681.
Crossref
Agata Gitlin-Domagalska, Dawid Dębowski, Aleksandra Maciejewska, Sergey Samsonov, Martyna Maszota-Zieleniak, Natalia Ptaszyńska, Anna Łęgowska & Krzysztof Rolka. (2023) Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry. ACS Medicinal Chemistry Letters 14:4, pages 458-465.
Crossref
Dongyan Feng, Le Ren, Jiaqi Wu, Lingling Guo, Zhitao Han, Jingjing Yang, Wei Xie, Yanbing Wang, Fanxing Xu, Xin Su, Dahong Li & Hao Cao. (2023) Permethrin as a Potential Furin Inhibitor through a Novel Non-Competitive Allosteric Inhibition. Molecules 28:4, pages 1883.
Crossref
Li Ni, Pin Li, Mingming Li, Shuhong Huang & Ningning Dang. (2022) SERPINB8 and furin regulate ITGAX expression and affect the proliferation and invasion of melanoma cells . Experimental Dermatology 32:1, pages 24-29.
Crossref
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Marquez, Kawthar Mohamed, Lamin Ndow, Dorota Zarębska-Michaluk, Nima Rezaei & Piotr Rzymski. (2022) Oral antiviral treatments for COVID-19: opportunities and challenges. Pharmacological Reports 74:6, pages 1255-1278.
Crossref
Zhanfeng Liang, Zhaoqi Zhang, Qian Zhang, Xue Dong, Xiaofeng Yang, Jiayu Zhang, Tong Lei, John W.M. Creemers, Baojun Zhang & Yong Zhao. (2022) The proprotein convertase furin regulates the development of thymic epithelial cells to ensure central immune tolerance. iScience 25:10, pages 105233.
Crossref
Shailendra Pratap Singh, Aayushi Bhatnagar, Sujeet Kumar Singh, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal, Salomon Amar & Ranata Manna. (2022) SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics. Mini-Reviews in Medicinal Chemistry 22:16, pages 2102-2123.
Crossref
Ahmed M. Abu El‐Asrar, Mohd I. Nawaz, Ajmal Ahmad, Mohammad M. Siddiquei, Eef Allegaert, Priscilla W. Gikandi, Gert De Hertogh & Ghislain Opdenakker. (2022) Proprotein convertase furin is a driver and potential therapeutic target in proliferative diabetic retinopathy. Clinical & Experimental Ophthalmology 50:6, pages 632-652.
Crossref
Arijit Ghosh, Paritosh K. Kar, Anupam Gautam, Rahul Gupta, Rajveer Singh, Rudra Chakravarti, Velayutham Ravichandiran, Shubhra Ghosh Dastidar, Dipanjan Ghosh & Syamal Roy. (2022) An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives. RSC Medicinal Chemistry 13:6, pages 647-675.
Crossref
Digant Nayak, Elizabeth V. Wasmuth & Shaun K. Olsen. (2022) Clearing the air: Uniquely engaging furin as an approach to cystic fibrosis therapy. Cell Chemical Biology 29:6, pages 927-929.
Crossref
Lisa E.J. Douglas, James A. Reihill, Melisa W.Y. Ho, Jeffrey M. Axten, Nino Campobasso, Jessica L. Schneck, Alan R. Rendina, Keith M. Wilcoxen & S. Lorraine Martin. (2022) A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease. Cell Chemical Biology 29:6, pages 947-957.e8.
Crossref
Maryam Kianpour, Mohsen Akbarian & Vladimir N. Uversky. (2022) Nanoparticles for Coronavirus Control. Nanomaterials 12:9, pages 1602.
Crossref
Gary Thomas, Frédéric Couture & Anna Kwiatkowska. (2022) The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2. International Journal of Molecular Sciences 23:7, pages 3435.
Crossref
Zongsheng He, Abdel-Majid Khatib & John W. M. Creemers. (2022) The proprotein convertase furin in cancer: more than an oncogene. Oncogene 41:9, pages 1252-1262.
Crossref
Essam Eldin A. Osman, Alnawaz Rehemtulla & Nouri Neamati. (2021) Why All the Fury over Furin?. Journal of Medicinal Chemistry 65:4, pages 2747-2784.
Crossref
Manica Negahdaripour, Mohammad Reza Rahbar, Zahra Mosalanejad & Ahmad Gholami. (2022) Theta-Defensins to Counter COVID-19 as Furin Inhibitors: In Silico Efficiency Prediction and Novel Compound Design. Computational and Mathematical Methods in Medicine 2022, pages 1-15.
Crossref
Yuka Kiba, Rio Oyama, Sae Misawa, Takashi Tanikawa, Masashi Kitamura & Ryuichiro Suzuki. (2021) Screening for inhibitory effects of crude drugs on furin-like enzymatic activities. Journal of Natural Medicines 75:4, pages 1080-1085.
Crossref
Adam W. Akerman, Elizabeth N. Collins, Andrew R. Peterson, Lauren B. Collins, Jessica K. Harrison, Amari DeVaughn, Jaleel M. Townsend, Rebecca L. Vanbuskirk, Jessica Riopedre‐Maqueira, Ailet Reyes, Joyce E. Oh, Charles M. Raybuck, Jeffrey A. Jones & John S. Ikonomidis. (2021) miR‐133a Replacement Attenuates Thoracic Aortic Aneurysm in Mice. Journal of the American Heart Association 10:16.
Crossref
Zahra Sheybani, Maryam Heydari Dokoohaki, Manica Negahdaripour, Mehdi Dehdashti, Hassan Zolghadr, Mohsen Moghadami, Seyed Masoom Masoompour & Amin Reza Zolghadr. (2021) The interactions of folate with the enzyme furin: a computational study. RSC Advances 11:38, pages 23815-23824.
Crossref
Yidi Wu, Youliang Huang, Wenwu Zhang & Susan J. Gunst. (2021) The proprotein convertase furin inhibits IL-13-induced inflammation in airway smooth muscle by regulating integrin-associated signaling complexes. American Journal of Physiology-Lung Cellular and Molecular Physiology 321:1, pages L102-L115.
Crossref
N.R. Jena. (2021) Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2. Chemical Physics Impact 2, pages 100011.
Crossref
Manita Shakya & Iris Lindberg. (2021) Mouse Models of Human Proprotein Convertase Insufficiency. Endocrine Reviews 42:3, pages 259-294.
Crossref
Dengke Tian, Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaolin Xie, Dezhu Zhang, Minge Wan, Han Li, Xueqi Fu, Hong Liu & Wenqiang Cao. (2021) An update review of emerging small-molecule therapeutic options for COVID-19. Biomedicine & Pharmacotherapy 137, pages 111313.
Crossref
Areej M. AssafRanda N. HaddadinAmal A. Akour. (2021) COVID-19: Between Past and Present. Viral Immunology 34:3, pages 145-157.
Crossref
Monika A. Lewandowska-Goch, Anna Kwiatkowska, Teresa Łepek, Kévin Ly, Pauline Navals, Hugo Gagnon, Yves L. Dory, Adam Prahl & Robert Day. (2021) Design and Structure–Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin. ACS Medicinal Chemistry Letters 12:3, pages 365-372.
Crossref
Zsuzsanna Ortutay, Anna Grönholm, Melina Laitinen, Melinda Keresztes-Andrei, Ismail Hermelo & Marko Pesu. (2021) Identification of Novel Genetic Regulatory Region for Proprotein Convertase FURIN and Interferon Gamma in T Cells. Frontiers in Immunology 12.
Crossref
Mahamudul Haque, Ruby J Siegel, David A Fox & Salahuddin Ahmed. (2021) Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family. Rheumatology 60:2, pages 494-506.
Crossref
Rhea Conchita Gonsalves, Himavani Pacharla, Sai Manohar, Siva Kumar Belliraj, Ekta Tripathi, Prashanthi Karyala & Suresh B. Pakala. 2021. Pandemic Outbreaks in the 21st Century. Pandemic Outbreaks in the 21st Century 185 210 .
Marcel Alexander Heinrich, Byron Martina & Jai Prakash. (2020) Nanomedicine strategies to target coronavirus. Nano Today 35, pages 100961.
Crossref
Magda Gioia, Chiara Ciaccio, Paolo Calligari, Giovanna De Simone, Diego Sbardella, Grazia Tundo, Giovanni Francesco Fasciglione, Alessandra Di Masi, Donato Di Pierro, Alessio Bocedi, Paolo Ascenzi & Massimo Coletta. (2020) Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches. Biochemical Pharmacology 182, pages 114225.
Crossref
Carmen Gil, Tiziana Ginex, Inés Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria E. Campillo & Ana Martinez. (2020) COVID-19: Drug Targets and Potential Treatments. Journal of Medicinal Chemistry 63:21, pages 12359-12386.
Crossref
Qiongqiong Angela Zhou, Junko Kato-Weinstein, Yingzhu Li, Yi Deng, Roger Granet, Linda Garner, Cynthia Liu, Dmitrii Polshakov, Chris Gessner & Steven Watkins. (2020) Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections. ACS Pharmacology & Translational Science 3:5, pages 813-834.
Crossref
Prasenjit Mitra. (2020) Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection. American Journal of Physiology-Cell Physiology 319:3, pages C500-C509.
Crossref
Naveen Vankadari. (2020) Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence. The Journal of Physical Chemistry Letters 11:16, pages 6655-6663.
Crossref
Zongsheng He, Abdel-Majid Khatib & John W.M. Creemers. (2020) Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer. Cancer Letters 484, pages 40-49.
Crossref
Elisa Barile, Carlo Baggio, Luca Gambini, Sergey A. Shiryaev, Alex Y. Strongin & Maurizio Pellecchia. (2020) Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming. Molecules 25:10, pages 2424.
Crossref
Zongsheng He, Lieven Thorrez, Geraldine Siegfried, Sandra Meulemans, Serge Evrard, Sabine Tejpar, Abdel-Majid Khatib & John W. M. Creemers. (2020) The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer. Oncogene 39:17, pages 3571-3587.
Crossref
Diana Farhat, Sophie Léon, Sandra E. Ghayad, Nicolas Gadot, Philippe Icard, Muriel Le Romancer, Nader Hussein & Hubert Lincet. (2020) Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation. British Journal of Cancer 122:6, pages 885-894.
Crossref
Geraldine Siegfried, Jean Descarpentrie, Serge Evrard & Abdel-Majid Khatib. (2020) Proprotein convertases: Key players in inflammation-related malignancies and metastasis. Cancer Letters 473, pages 50-61.
Crossref
Jacobo Elíes, Matilde Yáñez, Thiago M. C. Pereira, José Gil-Longo, David A. MacDougall & Manuel Campos-Toimil. 2020. Calcium Signaling. Calcium Signaling 183 213 .
Karin Löw, Kornelia Hardes, Chiara Fedeli, Nabil G. Seidah, Daniel B. Constam, Antonella Pasquato, Torsten Steinmetzer, Alexandre Roulin & Stefan Kunz. (2019) A novel cell‐based sensor detecting the activity of individual basic proprotein convertases. The FEBS Journal 286:22, pages 4597-4620.
Crossref
Imran, Saleemi, Chen, Wang, Zhou, Li, Zhao, Zheng, Li, Cao & Ye. (2019) Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage. Viruses 11:11, pages 1011.
Crossref
T. V. Osadchuk, V. K. Kibirev & O. V. Shybyryn. (2019) 1,3-Oxazol-4-ylphosphonium salts as new non-peptide inhibitors of furin. The Ukrainian Biochemical Journal 91:4, pages 5-16.
Crossref
Kenneth H. Pearce, Laurie K. Overton, Robert T. Gampe, George B. Barrett, J. David Taylor, David D. McKee, Nino Campobasso, Robert T. Nolte & Robert A. Reid. (2019) BacMam production and crystal structure of nonglycosylated apo human furin at 1.89 Å resolution. Acta Crystallographica Section F Structural Biology Communications 75:4, pages 239-245.
Crossref
Gopala K. YakalaHector A. Cabrera-FuentesGustavo E. Crespo-AvilanChutima RattanasopaAlexandrina BurlacuBenjamin L. GeorgeKaviya AnandDavid Castaño MayanMaria CorlianòSauri Hernández-ReséndizZihao WuAnne M.K. SchwerkAmberlyn L.J. TanLaia Trigueros-MotosRaphael ChèvreTricia ChuaRobert KleemannElisa A. LiehnDerek J. HausenloySujoy GhoshRoshni R. Singaraja. (2019) FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 39:3, pages 387-401.
Crossref
Benjamin J. Samelson-Jones & Valder R. Arruda. (2019) Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy. Molecular Therapy - Methods & Clinical Development 12, pages 184-201.
Crossref
Elisabeth Braun & Daniel Sauter. (2019) Furin‐mediated protein processing in infectious diseases and cancer. Clinical & Translational Immunology 8:8.
Crossref
T. V. Osadchuk, O. V. Shybyryn, A. V. Semyroz & V. K. Kibirev. (2018) Influence of organic solvents on the furin activity. The Ukrainian Biochemical Journal 90:5, pages 28-33.
Crossref
Theo Klein, Ulrich Eckhard, Antoine Dufour, Nestor Solis & Christopher M. Overall. (2017) Proteolytic Cleavage—Mechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification. Chemical Reviews 118:3, pages 1137-1168.
Crossref
Junko Hasegawa-Minato, Masafumi Toyoshima, Masumi Ishibashi, Xuewei Zhang, Shogo Shigeta, Carla Grandori, Kazuyuki Kitatani & Nobuo Yaegashi. (2017) Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers. Oncotarget 9:3, pages 3483-3496.
Crossref
Patricia Jaaks & Michele Bernasconi. (2017) The proprotein convertase furin in tumour progression. International Journal of Cancer 141:4, pages 654-663.
Crossref
N. I. Solovyeva, T. A. Gureeva, O. S. Timoshenko, T. A. Moskvitina & E. V. Kugaevskaya. (2017) Furin as proprotein convertase and its role in normal and pathological biological processes. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 11:2, pages 87-100.
Crossref
Daniel E. Bassi, Jirong Zhang, Catherine Renner & Andres J. Klein-Szanto. (2017) Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. Molecular Carcinogenesis 56:3, pages 1182-1188.
Crossref
N.I. Solovyeva, T.A. Gureeva, O.S. Timoshenko, T.A. Moskvitina & E.V. Kugaevskaya. (2016) Furin as proprotein convertase and its role in normal and pathological biological processes. Biomeditsinskaya Khimiya 62:6, pages 609-621.
Crossref
Joshua I. Siner, Benjamin J. Samelson-Jones, Julie M. Crudele, Robert A. French, Benjamin J. Lee, Shanzhen Zhou, Elizabeth Merricks, Robin Raymer, Timothy C. Nichols, Rodney M. Camire & Valder R. Arruda. (2016) Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models. JCI Insight 1:16.
Crossref
Jingwen Wang, Yuhong Huang, Jun Zhang, Yuanyi Wei, Salma Mahoud, Ahmed Musa Hago Bakheet, Li Wang, Shuting Zhou & Jianwu Tang. (2016) Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis. Clinica Chimica Acta 461, pages 165-171.
Crossref
Zuzet Martinez Cordova, Anna Grönholm, Ville Kytölä, Valentina Taverniti, Sanna Hämäläinen, Saara Aittomäki, Wilhelmiina Niininen, Ilkka Junttila, Antti Ylipää, Matti Nykter & Marko Pesu. (2016) Myeloid cell expressed proprotein convertase FURIN attenuates inflammation. Oncotarget 7:34, pages 54392-54404.
Crossref
Anna Kwiatkowska, Frédéric Couture, Christine Levesque, Kévin Ly, Sophie Beauchemin, Roxane Desjardins, Witold Neugebauer, Yves L. Dory & Robert Day. (2016) Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors. ChemMedChem 11:3, pages 289-301.
Crossref
Zdeněk Franta, Heiko Vogel, Rüdiger Lehmann, Oliver Rupp, Alexander Goesmann & Andreas Vilcinskas. (2016) Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots . BioMed Research International 2016, pages 1-27.
Crossref
Heiko Fittler, Alexander Depp, Olga Avrutina, Sven O. Dahms, Manuel E. Than, Martin Empting & Harald Kolmar. (2015) Engineering a Constrained Peptidic Scaffold towards Potent and Selective Furin Inhibitors. ChemBioChem 16:17, pages 2441-2444.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.